serialization solutions

Taking place in Paris from 7-8 February, Pharmapack Europe will be the premier destination for pharma companies and CMOs searching for alternative serialization solutions. As the industry enters stretch runs for several high-profile serialization mandates, the time is now for companies struggling to comply to reimagine their track & trace architecture in favor of more nimble, far-reaching solutions.

At Pharmapack, Adents will showcase its latest innovations (Stand G66, Hall 7.1), specifically business intelligence capabilities, optimized connectivity tools, and a HoloLens application accompanying Prodigi. Moreover, Christophe Carissimo, customer service director at Adents, will give a presentation titled  ‘How to ensure reliable and seamless management, sharing and reporting of your serialization data’  during the ‘Serialization and Track & Trace’ Symposium on 7 February.

Over the last months, leading serialization solutions provider  Adents  has noticed that many pharma companies – including large industry players – have experienced onerous difficulties in deploying serialization. In most instances, these implementations failed because the software solution could not seamlessly adapt to regulatory changes, or manage new requirements for additional markets, without time-consuming, resource-laden coding jobs.

Given the looming deadlines to comply with the Drug Supply Chain Security Act (DSCSA) in the US and the EU Falsified Medicines Directive (FMD), and also the numbers of packaging lines to be upgraded, large pharma companies are turning to Adents’ innovative, robust solutions to help them master serialization data utilization and maximize its business potential.

With its two serialization solutions,  Adents Seriza  (for manufacturing sites), and  Adents Prodigi  (for marketing authorization holders), Adents is differentiating itself through several crucial factors, including permanent compliance, end-to-end data management, widest connectivity and global network of serialization experts.

“Our experience shows that the most critical step for pharma companies to successfully achieve serialization compliance is effectively adapt their information system architecture. From the packaging line to the patient, they need a versatile serialization solution that can properly generate, transfer and secure their serialization data,”  said Christophe Devins, chief executive officer of Adents.

Packaging South Asia — authentic, impactful and influential

An English-language packaging industry B2B platform in print and web, Packaging South Asia is in its 19th year of publication. We do not make any claims about being the best or the most widely read. However, if you are interested in targeting the Indian and South Asian markets to sell equipment, technology, software, and consumables, we can help.

To improve your marketing and grow sales, talk to us. Our research and consulting company IppStar [www.ippstar.org] can assess your potential and addressable markets in light of the competition. We can discuss marketing, communication, and sales strategies for market entry and growth.

Suppliers and service providers with a strategy and budget for targeted marketing can discuss using our hybrid print, web, video, and social media channels to create brand recognition linked to market relevance. Our platform and channels are differentiated by hands-on practice and an understanding of business and financials. Our team, including some of the best technical writers, is ready to meet you and your customers for content.

India and South Asia’s fast-growing packaging industry is continuously expanding capacities with efficiency and appropriate innovative technologies. Get our 2025 media kit and recalibrate your role in this dynamic market. Enhance your visibility and relevance to existing markets and turn potential customers into conversations. Ask for a sample copy of our monthly or two weekly packaging eZines.

For editorial info@ippgroup.in — for advertisement ads1@ippgroup.in and for subscriptions subscription@ippgroup.in

Naresh Khanna – 21 January 2025

Subscribe Now
unnamed 1

NEWSLETTER

Subscribe to our Newsletter

LEAVE A REPLY

Please enter your comment!
Please enter your name here